Washington, D.C. - Today, Congresswoman Elise Stefanik co-led the introduction of the Confronting CCP Human Rights Abusers Act with Congressman Andy Ogles (R-TN) and Chairman of the Select Committee on the Chinese Communist Party (CCP) John Moolenaar (R-MI) to direct the Biden Administration to re-list Communist China’s Ministry of Public Security’s (MPS) Institute of Forensic Science on the U.S.’s Bureau of Industry and Security of the Department of Commerce’s Entity List.
The CCP’s Institute of Forensic Science was sanctioned by the Trump Administration for using DNA to track its own people and collect genetic information on Uyghur detainees. The Biden Administration removed trade sanctions against the MPS’s Institute of Forensic Science in November.
“Joe Biden has unacceptably chosen to reward a Communist Chinese company despite their genocidal crimes and human rights abuses against the Uyghur population and other ethnic minorities. This legislation to relist China’s Institute of Forensic Science on our Entity List will return us to President Trump’s peace through strength strategy and ensure no U.S. technology is benefiting Communist China’s human rights abuses,” said Congresswoman Elise Stefanik.
“The Chinese Communist Party (CCP) has a long and sordid history of human rights abuses, and its Institute of Forensic Science is no exception. President Trump took decisive action to sanction the Institute in June 2020, placing it on the Entity List for its material support for the genocide of the Uighurs. President Biden lifted the sanctions in November 2023 and removed the Institute from the Entity List – without proving that the Institute had stopped participating in mass slaughter,” said Congressman Andy Ogles. “It’s past time for the US to confront the CCP’s human rights abusers, and Congress will have to lead in the absence of a strong Commander-in-Chief. I am incredibly grateful for the support of the Select Committee on the CCP Chairman Moolenaar and GOP Conference Chairwoman Stefanik.”
“Secretary Blinken has often argued that human rights should be at the forefront of our foreign policy. Unfortunately, the administration did not follow its own principle when it delisted a Chinese entity implicated in genocide in exchange for yet more unproductive talks about fentanyl—even though we now know the Chinese Communist Party is fueling that crisis. Rewarding the CCP for committing one human rights atrocity will only empower it to worsen the others,” said Chairman John Moolenaar.
